Related references
Note: Only part of the references are listed.Suppression of Human Solid Tumor Growth in Mice by Intratumor and Systemic Inoculation of Histidine-Rich and pH-Dependent Host Defense-like Lytic Peptides
Arik Makovitzki et al.
CANCER RESEARCH (2009)
The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells
Seth B. Coffelt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer
Guenther Weber et al.
BREAST CANCER RESEARCH (2009)
Studies on anticancer activities of antimicrobial peptides
David W. Hoskin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2008)
Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines
Joerg T. Hartmann
ANTI-CANCER DRUGS (2007)
Anticancer α-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes
Sarah R. Dennison et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2006)
The co-evolution of host cationic antimicrobial peptides and microbial resistance
Andreas Peschel et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Antitumor activity of the antimicrobial peptide Magainin II against bladder cancer cell lines
Jan Lehmann et al.
EUROPEAN UROLOGY (2006)
Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide
Niv Papo et al.
CANCER RESEARCH (2006)
Changes in electric charge and phospholipids composition in human colorectal cancer cells
I Dobrzynska et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Surface exposure of phosphatidylserine in pathological cells
RFA Zwaal et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells
JD Heilborn et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Host defense peptides as new weapons in cancer treatment
N Papo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino acid peptide: Membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion
N Papo et al.
CANCER RESEARCH (2004)
Membrane disrupting lytic peptides for cancer treatments
C Leuschner et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
A novel lytic peptide composed of DL-Amino acids selectively kills cancer cells in culture and in mice
N Papo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Selective targeting of cancer cells using synthetic peptides
M Shadidi et al.
DRUG RESISTANCE UPDATES (2003)
Antimicrobial peptides of multicellular organisms
M Zasloff
NATURE (2002)
Analysis of drug transport kinetics in implications for drug action
A Garnier-Suillerot et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Crystallization of antimicrobial pores in membranes: Magainin and protegrin
L Yang et al.
BIOPHYSICAL JOURNAL (2000)
Share Paper
